EP2785874A4 - Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support - Google Patents

Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support

Info

Publication number
EP2785874A4
EP2785874A4 EP12854522.5A EP12854522A EP2785874A4 EP 2785874 A4 EP2785874 A4 EP 2785874A4 EP 12854522 A EP12854522 A EP 12854522A EP 2785874 A4 EP2785874 A4 EP 2785874A4
Authority
EP
European Patent Office
Prior art keywords
anesthesia
decision support
risk identification
pain management
therapeutic decision
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP12854522.5A
Other languages
German (de)
French (fr)
Other versions
EP2785874A1 (en
EP2785874B1 (en
Inventor
Senthilkumar Sadhasivam
Vidya Chidambaran
John Mcauliffe
Kejian Zhang
Jarolsaw Meller
Cynthia A Prows
Tsuyoshi Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Childrens Hospital Medical Center
Original Assignee
Cincinnati Childrens Hospital Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center filed Critical Cincinnati Childrens Hospital Medical Center
Priority to EP18196397.6A priority Critical patent/EP3483288B1/en
Publication of EP2785874A1 publication Critical patent/EP2785874A1/en
Publication of EP2785874A4 publication Critical patent/EP2785874A4/en
Application granted granted Critical
Publication of EP2785874B1 publication Critical patent/EP2785874B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
EP12854522.5A 2011-11-30 2012-11-29 Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support Not-in-force EP2785874B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP18196397.6A EP3483288B1 (en) 2011-11-30 2012-11-29 Personalized pain management and anesthesia: preemptive risk identification

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161565400P 2011-11-30 2011-11-30
US201261661073P 2012-06-18 2012-06-18
PCT/US2012/067111 WO2013082308A1 (en) 2011-11-30 2012-11-29 Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP18196397.6A Division EP3483288B1 (en) 2011-11-30 2012-11-29 Personalized pain management and anesthesia: preemptive risk identification

Publications (3)

Publication Number Publication Date
EP2785874A1 EP2785874A1 (en) 2014-10-08
EP2785874A4 true EP2785874A4 (en) 2015-08-19
EP2785874B1 EP2785874B1 (en) 2018-09-26

Family

ID=48536065

Family Applications (2)

Application Number Title Priority Date Filing Date
EP18196397.6A Active EP3483288B1 (en) 2011-11-30 2012-11-29 Personalized pain management and anesthesia: preemptive risk identification
EP12854522.5A Not-in-force EP2785874B1 (en) 2011-11-30 2012-11-29 Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP18196397.6A Active EP3483288B1 (en) 2011-11-30 2012-11-29 Personalized pain management and anesthesia: preemptive risk identification

Country Status (3)

Country Link
US (5) US9944985B2 (en)
EP (2) EP3483288B1 (en)
WO (1) WO2013082308A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8930178B2 (en) 2007-01-04 2015-01-06 Children's Hospital Medical Center Processing text with domain-specific spreading activation methods
EP3483288B1 (en) 2011-11-30 2022-03-16 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification
US20140274763A1 (en) * 2013-03-15 2014-09-18 Pathway Genomics Corporation Method and system to predict response to pain treatments
JP6539274B2 (en) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド Extruded immediate release abuse deterrent pills
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2940422A1 (en) * 2014-02-24 2015-08-27 Children's Hospital Medical Center Methods and compositions for personalized pain management
CN104144420B (en) * 2014-02-26 2015-11-25 腾讯科技（深圳）有限公司 A kind of radio switch-in method and relevant device, system
JP6371463B2 (en) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド Immediate release abuse deterrent liquid filler form
EP3177738B1 (en) 2014-08-08 2019-10-09 Children's Hospital Medical Center Diagnostic method for distinguishing forms of esophageal eosinophilia
EP2987451A1 (en) 2014-08-18 2016-02-24 Tools 4 Patient sa Method and tools for predicting a pain response in a subject
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2016176475A2 (en) * 2015-04-28 2016-11-03 Proove Biosciences, Inc. System and method for processing genotype information relating to opioid response
US20180322960A1 (en) * 2015-04-28 2018-11-08 Proove Biosciences, Inc. System and method for processing genotype information relating to nsaid risk
WO2017059022A1 (en) * 2015-09-30 2017-04-06 Inform Genomics, Inc. Systems and methods for predicting treatment-regiment-related outcomes
TWI626617B (en) * 2015-12-11 2018-06-11 義守大學 Method for estimating anesthesia risk
EP3402572B1 (en) 2016-01-13 2022-03-16 Children's Hospital Medical Center Compositions and methods for treating allergic inflammatory conditions
EP3571309A4 (en) 2017-01-20 2020-11-25 Children's Hospital Medical Center Methods and compositions relating to oprm1 dna methylation for personalized pain management
US10426400B2 (en) 2017-06-23 2019-10-01 International Business Machines Corporation Optimized individual sleep patterns
US11011264B2 (en) 2017-08-09 2021-05-18 Varian Medical Systems International Ag Radiotherapy treatment planning using artificial intelligence (AI) engines
US11859250B1 (en) 2018-02-23 2024-01-02 Children's Hospital Medical Center Methods for treating eosinophilic esophagitis
EP3813814A4 (en) * 2018-06-28 2022-06-29 Children's Hospital Medical Center Methods and compositions relating to personalized pain management
WO2020172432A1 (en) * 2019-02-21 2020-08-27 Children's Hospital Medical Center Methods and compositions for the detection, classification, and diagnosis of chronic post-surgical pain
US20200329698A1 (en) * 2019-04-19 2020-10-22 Nobilis Therapeutics, Inc. Compositions for organ graft preservation and methods of use
CN111455038B (en) * 2020-04-07 2021-03-05 上海康黎医学检验所有限公司 Kit for guiding drug for anxiety disorder of human and application thereof
WO2021211575A1 (en) * 2020-04-13 2021-10-21 The Regents Of The Univefisity Of California Compositions comprising propofol, ketamine, and non-opioid analgesic, and methods of use
CN112980946B (en) * 2021-04-28 2022-08-26 华中科技大学同济医学院附属协和医院 Gene polymorphism detection kit and detection method for guiding administration of rocuronium bromide serving as skeletal muscle relaxant
WO2023102425A1 (en) * 2021-11-30 2023-06-08 East Carolina University Methods for determining opioid responsiveness in the treatment of pain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009067473A2 (en) * 2007-11-20 2009-05-28 Wisconsin Alumni Research Foundation Method of improving palliative care

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5148483A (en) 1983-08-11 1992-09-15 Silverman Stephen E Method for detecting suicidal predisposition
US4675904A (en) 1983-08-11 1987-06-23 Compusonics, Inc. Method for detecting suicidal predisposition
US5976081A (en) 1983-08-11 1999-11-02 Silverman; Stephen E. Method for detecting suicidal predisposition
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US6287850B1 (en) 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
DE69527585T2 (en) 1994-06-08 2003-04-03 Affymetrix Inc Method and device for packaging chips
US6300063B1 (en) 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
WO1997045559A1 (en) 1996-05-29 1997-12-04 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US8301468B2 (en) 2000-05-15 2012-10-30 Optuminsight, Inc. System and method of drug disease matching
JP2004514418A (en) * 2000-07-11 2004-05-20 ホーガン　カーク Methods and compositions for perioperative genome profiling
US7062443B2 (en) 2000-08-22 2006-06-13 Silverman Stephen E Methods and apparatus for evaluating near-term suicidal risk using vocal parameters
US7139699B2 (en) 2000-10-06 2006-11-21 Silverman Stephen E Method for analysis of vocal jitter for near-term suicidal risk assessment
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
AU2002366713A1 (en) 2001-12-20 2003-07-09 Incyte Genomics, Inc. Nucleotide polymorphisms associated with osteoarthritis
US7716207B2 (en) 2002-02-26 2010-05-11 Odom Paul S Search engine methods and systems for displaying relevant topics
WO2005105093A2 (en) 2003-08-26 2005-11-10 Duke University METHOD OF ARRESTING THE SIDE EFFECTS OF µ-OPIOID RECEPTOR AGONISTS DURING THEIR ADMINISTRATION
JP3793213B2 (en) 2003-09-01 2006-07-05 株式会社ソニー・コンピュータエンタテインメント Network game terminal, game server, method executed on network game terminal, and recording medium
US20080020476A1 (en) 2004-03-31 2008-01-24 Kazutaka Ikeda Method Of Evaluating Drug Sensitivity By Analyzing The Mu-Opioid Receptor Gene
WO2006119343A1 (en) 2005-05-03 2006-11-09 Children's Hospital Medical Center Determination of eosinophilic esophagitis
WO2007070252A2 (en) * 2005-11-30 2007-06-21 The University Of North Carolina At Chapel Hill Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same
US7754428B2 (en) 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
JP5308644B2 (en) 2006-08-31 2013-10-09 公益財団法人東京都医学総合研究所 Drug sensitivity evaluation method by GIRK channel gene analysis
US7899764B2 (en) 2007-02-16 2011-03-01 Siemens Aktiengesellschaft Medical ontologies for machine learning and decision support
JPWO2008133329A1 (en) 2007-04-25 2010-07-29 財団法人 東京都医学研究機構 Evaluation method of drug sensitivity by POMC gene analysis
US8249225B2 (en) 2008-03-14 2012-08-21 International Business Machines Corporation Identifying caller preferences based on voice print analysis
US20110257098A1 (en) 2008-11-26 2011-10-20 Merck Serono S.A. Compositions and methods for treating growth hormone deficiency
US8497066B2 (en) 2008-12-04 2013-07-30 Rush University Medical Center DNA methylation based test for monitoring efficacy of treatment
EP3522172B1 (en) 2009-04-27 2021-10-20 Children's Hospital Medical Center Method for assessing a neuropsychiatric condition of a human subject
GB2483108A (en) 2010-08-27 2012-02-29 Walid Juffali Monitoring neurological electrical signals to detect the onset of a neurological episode
JP6053267B2 (en) 2010-09-03 2016-12-27 公益財団法人東京都医学総合研究所 Evaluation method of drug sensitivity and disease vulnerability by adrenergic receptor gene analysis
US8694335B2 (en) 2011-02-18 2014-04-08 Nuance Communications, Inc. Methods and apparatus for applying user corrections to medical fact extraction
US9928344B2 (en) 2011-06-21 2018-03-27 Children's Hospital Medical Center Diagnostic methods of eosinophilic esophagitis
EP3483288B1 (en) 2011-11-30 2022-03-16 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification
WO2013126834A1 (en) 2012-02-24 2013-08-29 Children's Hospital Medical Center Esophageal microrna expression profiles in eosinophilic esophagitis
WO2013155010A1 (en) 2012-04-09 2013-10-17 Children's Hospital Medical Center Non-invasive biomarkers for eosinophilic esophagitis
US8377657B1 (en) 2012-05-15 2013-02-19 Predictive Biosciences Corporation Primers for analyzing methylated sequences and methods of use thereof
WO2014059178A1 (en) 2012-10-10 2014-04-17 Rhode Island Hospital Differential expression of novel protein markers for the diagnosis and treatment of eosinophilic esophagitis
WO2014190269A1 (en) 2013-05-24 2014-11-27 Children's Hospital Medical Center System and method for assessing suicide risk of a patient based upon non-verbal characteristics of voice data
EP3028190B1 (en) 2013-08-01 2022-06-22 Children's Hospital Medical Center Identification of surgery candidates using natural language processing
CA2940422A1 (en) 2014-02-24 2015-08-27 Children's Hospital Medical Center Methods and compositions for personalized pain management
EP3177738B1 (en) 2014-08-08 2019-10-09 Children's Hospital Medical Center Diagnostic method for distinguishing forms of esophageal eosinophilia
EP3571309A4 (en) 2017-01-20 2020-11-25 Children's Hospital Medical Center Methods and compositions relating to oprm1 dna methylation for personalized pain management
EP3813814A4 (en) 2018-06-28 2022-06-29 Children's Hospital Medical Center Methods and compositions relating to personalized pain management

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009067473A2 (en) * 2007-11-20 2009-05-28 Wisconsin Alumni Research Foundation Method of improving palliative care

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
COULBAULT ET AL: "Environmental and genetic factors associated with morphine response in the postoperative period", CLINICAL PHARMACOLOGY AND THERAPEUTICS, NATURE PUBLISHING GROUP, US, vol. 79, no. 4, 1 April 2006 (2006-04-01), pages 316 - 324, XP005406427, ISSN: 0009-9236, DOI: 10.1016/J.CLPT.2006.01.007 *
DE GREGORI M ET AL: "Individualizing pain therapy with opioids: The rational approach based on pharmacogenetics and pharmacokinetics", EUROPEAN JOURNAL OF PAIN SUPPLEMENTS, ELSEVIER, AMSTERDAM, NL, vol. 4, no. 4, 1 November 2010 (2010-11-01), pages 245 - 250, XP027461235, ISSN: 1754-3207, [retrieved on 20101101], DOI: 10.1016/J.EUJPS.2010.09.011 *
EIVOR A LAUGSAND ET AL: "Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids", EUROPEAN JOURNAL OF CANCER, PERGAMON, vol. 47, no. 11, 11 April 2011 (2011-04-11), pages 1682 - 1691, XP028323634, ISSN: 0959-8049, [retrieved on 20110415], DOI: 10.1016/J.EJCA.2011.04.014 *
K. T. S. PATTINSON: "Opioids and the control of respiration", BRITISH JOURNAL OF ANAESTHESIA, vol. 100, no. 6, 1 May 2008 (2008-05-01), pages 747 - 758, XP055200824, ISSN: 0007-0912, DOI: 10.1093/bja/aen094 *
KLEINE-BRUEGGENEY M ET AL: "Pharmacogenetics in palliative care", FORENSIC SCIENCE INTERNATIONAL, ELSEVIER SCIENTIFIC PUBLISHERS IRELAND LTD, IE, vol. 203, no. 1-3, 15 December 2010 (2010-12-15), pages 63 - 70, XP027514419, ISSN: 0379-0738, [retrieved on 20100814], DOI: 10.1016/J.FORSCIINT.2010.07.003 *
ROSS JOY R ET AL: "Genetic variation and response to morphine in cancer patients - Catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects", CANCER, vol. 112, no. 6, March 2008 (2008-03-01), pages 1390 - 1403, XP009185223, ISSN: 0008-543X *
SADHASIVAM S ET AL: "Pharmacogenetics and personalizing perioperative analgesia in children", JOURNAL OF PAIN, SAUNDERS, PHILADELPHIA, PA, US, vol. 11, no. 4, 1 April 2010 (2010-04-01), pages S50, XP027094770, ISSN: 1526-5900, [retrieved on 20100401] *
ZWISLER STINE T ET AL: "The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes", FUNDAMENTAL & CLINICAL PHARMACOLOGY, vol. 24, no. 4, August 2010 (2010-08-01), pages 517 - 524, XP002741938, ISSN: 0767-3981 *

Also Published As

Publication number Publication date
US20200308648A1 (en) 2020-10-01
EP3483288B1 (en) 2022-03-16
WO2013082308A1 (en) 2013-06-06
US10662476B2 (en) 2020-05-26
US20140371256A1 (en) 2014-12-18
EP3483288A3 (en) 2019-06-05
US11746377B2 (en) 2023-09-05
US20200318194A1 (en) 2020-10-08
EP2785874A1 (en) 2014-10-08
EP3483288A2 (en) 2019-05-15
US11597978B2 (en) 2023-03-07
US20200340061A1 (en) 2020-10-29
EP2785874B1 (en) 2018-09-26
US20180334717A1 (en) 2018-11-22
US9944985B2 (en) 2018-04-17

Similar Documents

Publication Publication Date Title
EP2785874A4 (en) Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
EP2755720A4 (en) Systems and methods for apnea therapy
AP2013007178A0 (en) BCMA-based stratification and therapy for multiplemyeloma patients
EP2750634A4 (en) Devices and methods for cervical lateral fixation
EP2760390A4 (en) Nasal insert and cannula and methods for the use thereof
EP2589403A4 (en) Anesthetic inhalation-assisting device and attachment thereof
EP2542147A4 (en) Devices and methods for treating psychological disorders
EP2745874A4 (en) Skin dose evaluation-assisting device and therapeutic planning device
EP2801059A4 (en) System and method for patient care plan management
EP2672916A4 (en) Patient positioning systems and methods
EP2699199A4 (en) Systems and methods for bariatric therapy
EP2753283A4 (en) Patient support and transport system
EP2773410A4 (en) Ventilator and medical device and method
GB2505604B (en) Device for inducing and maintaining sleep
HK1201454A1 (en) Therapeutic agents and uses thereof
HK1211249A1 (en) Device and methods for targeted tissue drug delivery
EP2665031A4 (en) Medical information management system and management device
HK1195484A1 (en) Medical treatment device and medical treatment method
HK1207593A1 (en) Medicament for treating mental and behavioural disorders
ZA201404070B (en) Cannula top and system
EP2734149A4 (en) Devices and methods for treating sleep disordered breathing
EP2696885A4 (en) Methods for chronic pain management and treatment using hcg
ZA201304619B (en) Moldable injury therapy device and method
GB201112260D0 (en) Medical device and related methods
GB201102227D0 (en) Inventions and therapy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MCAULIFFE, JOHN

Inventor name: PROWS, CYNTHIA A.

Inventor name: SADHASIVAM, SENTHILKUMAR

Inventor name: FUKUDA, TSUYOSHI

Inventor name: ZHANG, KEJIAN

Inventor name: MELLER, JAROLSAW

Inventor name: CHILDAMBARAN, VIDYA

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SADHASIVAM, SENTHILKUMAR

Inventor name: CHIDAMBARAN, VIDYA

Inventor name: ZHANG, KEJIAN

Inventor name: PROWS, CYNTHIA A.

Inventor name: FUKUDA, TSUYOSHI

Inventor name: MCAULIFFE, JOHN

Inventor name: MELLER, JAROLSAW

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150721

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/12 20060101ALI20150713BHEP

Ipc: C12Q 1/68 20060101AFI20150713BHEP

Ipc: C07K 7/06 20060101ALI20150713BHEP

Ipc: C12N 15/11 20060101ALI20150713BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20170214

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20180504

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNGEN

Ref country code: AT

Ref legal event code: REF

Ref document number: 1046095

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012051606

Country of ref document: DE

RIN2 Information on inventor provided after grant (corrected)

Inventor name: ZHANG, KEJIAN

Inventor name: PROWS, CYNTHIA A.

Inventor name: MCAULIFFE, JOHN

Inventor name: FUKUDA, TSUYOSHI

Inventor name: SADHASIVAM, SENTHILKUMAR

Inventor name: CHIDAMBARAN, VIDYA

Inventor name: MELLER, JAROSLAW

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNGEN

RIN2 Information on inventor provided after grant (corrected)

Inventor name: FUKUDA, TSUYOSHI

Inventor name: ZHANG, KEJIAN

Inventor name: CHIDAMBARAN, VIDYA

Inventor name: MELLOR, JAROSLAW

Inventor name: PROWS, CYNTHIA A.

Inventor name: MCAULIFFE, JOHN

Inventor name: SADHASIVAM, SENTHILKUMAR

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20180926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181227

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1046095

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190126

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012051606

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181129

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20181130

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181130

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181130

26N No opposition filed

Effective date: 20190627

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181129

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181129

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20121129

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180926

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20211129

Year of fee payment: 10

Ref country code: FR

Payment date: 20211124

Year of fee payment: 10

Ref country code: DE

Payment date: 20211126

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20211122

Year of fee payment: 10

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602012051606

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20221129

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221129

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221129

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221130